Oral delivery of insulin with the eligen® technology: Mechanistic studies

Current Drug Delivery

Volumn 2, Issue 2, 2005, Pages 191-197

  Malkov, Dmitry ^a   Angelo, Robert ^a   Wang, Huai Zhen ^a   Flanders, Elizabeth ^a   Tang, Heather ^a   Gomez Orellana, Isabel ^a  

^a Emisphere Technologies Inc   (United States)

Author keywords

Caco 2 cells; Circular dichroism; Occludin; Oral insulin; Transcellular absorption

Indexed keywords

DRUG CARRIER; INSULIN; N [8 (2 HYDROXYBENZOYL)AMINO]CAPRYLATE; OCTANOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; COVALENT BOND; DIABETES CONTROL; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; GASTROINTESTINAL ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; TECHNOLOGY;

ABSORPTION; ADMINISTRATION, ORAL; CACO-2 CELLS; CAPRYLATES; DRUG DELIVERY SYSTEMS; HUMANS; INSULIN; PERMEABILITY; SOLUBILITY;

EID: 16844382684     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567201053586001     Document Type: Article

References (19)

1. Goldberg, M.; Gomez-Orellana, I., Natl. Rev. Drug Discov. 2003, 2, (4), 289-295.
2. Kidron, M.; Dinh, S.; Menachem, Y.; Abbas, R.; Variano, B.; Goldberg, M.; Arbit, E., Baron, H., Diabetic Medicine 2004, 21 (4), 354-357.
3. Clement, S.; Dandona, P.; Still, J. G.; Kosutic, G., Metabolism 2004, 53, (1), 54-58.
4. Kipnes, M.; Dandona, P.; Tripatliy, D.; Still, J. G.; Kosutic, G., Diabetes Care 2003, 26, (2), 421-426.
5. Clement, S.; Still, J. G.; Kosutic, G.; McAllister, R. G.; Diabetes Technol. Ther. 2002, 4, (4), 459-466.
6. Shah, R. B.; Ahsan, F.; Khan, M. A.; Critt. Rev. Ther. Drug Carrier Syst. 2002, 19, (2), 135-169.
7. Cleland, J. L.; Daugherty, A.; Mrsny, R., Curr. Opin. Biotechnol. 2001, 12, (2), 212-219.
8. Artursson, P.; Palm, K.; Luthman, K.; Adv. Drug Deliv. Rev. 2001, 46, (1-3), 27-43.
9. Biganzoli, E.; Cavenaghi, L. A.; Rossi, R.; Brunati, M. C.; Nolli, M. L., Farmaco. 1999, 54, (9), 594-599.
10. Meunier, V.; Bourrie, M.; Berger, Y.; Fabre, G., Cell Biol Toxicol 1995, 11, (3-4), 187-194.
11. Quan, Y. S.; Hattori, K.; Lundborg, E.; Fujita, T.; Murakami, M.; Muranishi, S.; Yamamoto, A., Biol. Pharm. Bull. 1998, 21, (6), 615-620.
12. Madara, J. L.; Stafford, J.; Barenberg, D.; Carlson, S., Am. J. Physiol. 1988, 254, (3 Pt 1), G416-423.
13. Madara, J. L.; Barenberg, D.; Carlson, S., J. Cell Biol. 1986, 102, (6), 2125-2136.
14. Madara, J. L., Am. J. Physiol. 1987, 255, (1 Pt 1), C171-175.
15. Semisotnov, G. V.; Rodionova, N. A.; Razgulyaev, O. I.; Uversky, V. N.; Gripas, A. F.; Gilmanshin, R. I., Biopolymers 1991, 31, (1), 119-128.
16. Uversky, V. N.; Winter, S.; Lober, G., Biophys. Chem. 1996, 60, (3), 79-88.
17. Hua, Q. X.; Ladbury, J. E.; Weiss, M. A., Biochemistry 1993, 52, (6), 1433-1442.
18. Greenfield, N. J., Methods Enzymol. 2004, 383, 282-317.
19. Sreerama, N.; Woody, R. W., Methods Enzymol. 2004, 383, 318-351.